Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines
Esmée C. de Baat, Renée L. Mulder, Saro H. Armenian, et al.
Cochrane library (2022)
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis
Panpan Tai, Xinyu Chen, Guihua Jia, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52
Anthracycline Cardiotoxicity in Adult Cancer Patients
Massimiliano Camilli, Carlo M. Cipolla, Susan Dent, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 655-677
Open Access | Times Cited: 21
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Esmée C. de Baat, Elvira C van Dalen, Renée L. Mulder, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 12, pp. 885-894
Closed Access | Times Cited: 39
Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
Hany Akeel Al-Hussaniy, Ali Hikmat Alburghaif, Zahraa Alkhafaje, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 4, pp. 491-500
Open Access | Times Cited: 32
Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo–Yap pathway to exacerbate doxorubicin-induced cardiotoxicity
Peng Zhao, You Li, Xiangli Xu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 15
Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial
Thomas H. Marwick, Elizabeth Dewar, Mark Nolan, et al.
European Heart Journal (2024)
Open Access | Times Cited: 9
Parkinson's disease and cardiovascular involvement: Edifying insights (Review)
Laura Grosu, Alin Grosu, Dana Crișan, et al.
Biomedical Reports (2023) Vol. 18, Iss. 3
Open Access | Times Cited: 19
Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity
Peter Henriksen, Stephen Rankin, Ninian N. Lang
JACC CardioOncology (2023) Vol. 5, Iss. 3, pp. 292-297
Open Access | Times Cited: 19
Preventing Anthracycline-Associated Heart Failure: What Is the Role of Dexrazoxane?
Haoyi Zheng, Huichun Zhan
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 318-321
Open Access | Times Cited: 8
Cardiovascular Considerations Before Cancer Therapy
Zahra Raisi‐Estabragh, A. Murphy, Sivatharshini Ramalingam, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 5, pp. 631-654
Open Access | Times Cited: 7
Dexrazoxane to Prevent Cardiotoxicity in Adults Treated with Anthracyclines
Jenica N. Upshaw, Susan K. Parson, Rachel J. Buchsbaum, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 322-324
Open Access | Times Cited: 6
Cardiovascular health of patients with cancer: Challenges abound
Jeffrey Shi Kai Chan, Raymond Chan, Yan Hiu Athena Lee, et al.
Trends in Cardiovascular Medicine (2024)
Open Access | Times Cited: 6
Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations
Jessica Tetterton-Kellner, Brian C. Jensen, Juliane Nguyen
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115361-115361
Closed Access | Times Cited: 6
Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients
Ying Zhao, Rui He, Sandra Oerther, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1797-1797
Open Access | Times Cited: 19
Capsaicin alleviates doxorubicin-induced acute myocardial injury by regulating iron homeostasis and PI3K-Akt signaling pathway
Longbin Wang, Ying Liu, Si Li, et al.
Aging (2023) Vol. 15, Iss. 21, pp. 11845-11859
Open Access | Times Cited: 12
Association of European Paediatric and Congenital Cardiology practical recommendations for surveillance and prevention of cardiac disease in childhood cancer survivors: the importance of physical activity and lifestyle changes From the Association of European Paediatric and Congenital Cardiology Working Group Sports Cardiology, Physical Activity and Prevention, Working Group Adult Congenital Heart Disease, Working Group Imaging and Working Group Heart Failure
Sabine Kesting, Ugo Giordano, Jochen Weil, et al.
Cardiology in the Young (2024) Vol. 34, Iss. 2, pp. 250-261
Open Access | Times Cited: 4
Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients With Hodgkin Lymphoma
Jenica N. Upshaw, Jason Nelson, Benjamin Sweigart, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 2, pp. 200-213
Open Access | Times Cited: 4
Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients
Chanisa Thonusin, Nichanan Osataphan, Krit Leemasawat, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity
Xuening Liu, Zijian Li
Basic Research in Cardiology (2024)
Closed Access | Times Cited: 4
Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation
Shin‐ichi Hirano, Yoshiyasu Takefuji
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1591-1591
Open Access | Times Cited: 4
Cardioprotection strategies for anthracycline cardiotoxicity
Andrea Moreno‐Arciniegas, Laura Cádiz, Carlos Galán‐Arriola, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 4
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
Marijke Linschoten, Jesse Geels, Erik van Werkhoven, et al.
Cardio-Oncology (2025) Vol. 11, Iss. 1
Open Access
Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment
Iacopo Fabiani, Michela Chianca, Carlo M. Cipolla, et al.
Nature Reviews Cardiology (2025)
Closed Access
Biomarkers for cancer therapy-related cardiovascular toxicity
Jiaxin Song, Shuqin Liu, Xiaohui Shi, et al.
International review of cell and molecular biology (2025)
Closed Access
Acute and Chronic Cardiovascular Adverse Events in Patients with Acute Myeloid Leukemia: A Systematic Review
Konstantinos C. Siaravas, Amalia Ioanna Moula, Ioannis Tzourtzos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 541-541
Open Access
Page 1 - Next Page

Scroll to top